Wicab Funding: How Much Did They Raise & Key Investors

How Much Did Wicab Raise?
Funding & Key Investors

Wicab has successfully secured a significant capital injection, bringing its total funding to $7.4M. This latest major strategic investment of $4M marks a pivotal milestone in the company's growth trajectory, signaling strong market confidence in its assistive technology portfolio. By consolidating its financial position through successive rounds, the firm is now well-positioned to accelerate its mission of delivering high-impact sensory substitution devices to global markets.

The progression from initial private equity backing in early 2016 to a robust Series B round underscores the scalability of Wicab's proprietary neuro-stimulation platforms. This influx of resources provides the necessary runway to transition from specialized research and development into broader commercial deployment, ensuring that their innovative solutions reach a wider demographic of individuals with visual and balance impairments.

What is Wicab?

Wicab

Manufacturing

Medical Devices & Equipment

Wicab operates at the intersection of neuroscience and assistive technology, pioneering solutions that translate sensory data into neural signals. The company's flagship BrainPort technology represents a breakthrough in sensory substitution, enabling the profoundly blind to perceive visual information through the tongue. Furthermore, the BrainPort Balance Plus serves as a critical biofeedback tool for clinical rehabilitation, addressing complex vestibular disorders. By leveraging non-invasive neuro-stimulation, Wicab has established a unique market position, effectively bridging the gap between medical necessity and consumer-grade independence. Their commitment to rigorous clinical validation and user-centric design has solidified their reputation as a leader in the assistive device sector, catering to a diverse clientele that demands both efficacy and reliability in their daily lives.

How much funding has Wicab raised?

Wicab has raised a total of $7.4M across 3 funding rounds:

2016

Multiple Rounds

$7.4M

Private Equity (2016): $974K, investors not publicly disclosed

Series A (2016): $2.4M, investors not publicly disclosed

Series B (2016): $4M, investors not publicly disclosed

Key Investors in Wicab

Undisclosed Investor

Undisclosed investor participating in the funding round.

Undisclosed Investor

Undisclosed investor participating in the funding round.

Undisclosed Investor

Undisclosed investor participating in the funding round.

What's next for Wicab?

With the recent infusion of capital, Wicab is poised to scale its manufacturing capabilities and expand its clinical footprint. The strategic focus will likely shift toward optimizing the BrainPort Vision Pro for mass-market accessibility while simultaneously exploring new therapeutic applications for their neuro-stimulation platform. As the company moves into this next phase of enterprise-level growth, stakeholders anticipate a concerted effort to secure additional regulatory clearances and forge partnerships with healthcare providers. This expansion strategy is designed to solidify Wicab's dominance in the assistive technology landscape, ensuring that their life-changing innovations remain at the forefront of medical technology advancements.

See full Wicab company page

See More Financial Insights